New TB vaccine tested in High-Risk south african communities
⭐️ VACCINE ⭐️
Recruiting now
This study is testing a new tuberculosis (TB) vaccine called MTBVAC to see if it is safe and if it triggers a good immune response. It involves 276 adolescents and adults in South Africa, including people living with and without HIV. Participants receive a single injection of eit…
Phase: PHASE2 • Sponsor: HIV Vaccine Trials Network • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 31, 2026 12:11 UTC